Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Ratliff

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
The Journal of Urology|July 1, 1990
In vitro and in vivo anti-tumor activity of recombinant mouse tumor necrosis factor (TNF) in a mouse bladder tumor (MBT-2)R R Bahnson, T L Ratliff
Acta Urologica Belgica|May 1, 1996
BCG treatment: current statusT L Ratliff, M A Hudson
Surgery Annual|January 1, 1990
Bacillus Calmette-Guérin and superficial bladder cancer. Clinical experience and mechanism of actionW J Catalona, T L Ratliff
Urologic Oncology|January 13, 2011
Failure of intravesical interferon-alfa-2b for the treatment of patients with superficial bladder cancer previously failing intravesical BCG TherapyM A Hudson, T L Ratliff
Cancer Treatment and Research|January 1, 1989
Mechanisms of action of intravesical bacillus Calmette-Guerin for bladder cancerD J Mikkelsen, T L Ratliff
In Vivo (Athens, Greece)|November 1, 1991
BCG therapy for superficial bladder cancer: fundamental aspectsM L Hudson, T L Ratliff
Hinyokika Kiyo. Acta Urologica Japonica|January 22, 1998
[Poxvirus vectors for gene transfer]M Kawakita, O Yoshida, T L Ratliff
Acta Urologica Belgica|May 1, 1996
Gene therapyA S Abi-Aad, T L Ratliff
The Journal of Urology|June 1, 1991
Internalization of bacille Calmette-Guerin by bladder tumor cellsM J Becich, S Carroll, T L Ratliff
The Journal of Urology|July 1, 1994
Development of a mouse model for nonbacterial prostatitisD W Keetch, P Humphrey, T L Ratliff
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
The Journal of Urology|July 1, 1990
In vitro and in vivo anti-tumor activity of recombinant mouse tumor necrosis factor (TNF) in a mouse bladder tumor (MBT-2)R R Bahnson, T L Ratliff
Acta Urologica Belgica|May 1, 1996
BCG treatment: current statusT L Ratliff, M A Hudson
Surgery Annual|January 1, 1990
Bacillus Calmette-Guérin and superficial bladder cancer. Clinical experience and mechanism of actionW J Catalona, T L Ratliff
Urologic Oncology|January 13, 2011
Failure of intravesical interferon-alfa-2b for the treatment of patients with superficial bladder cancer previously failing intravesical BCG TherapyM A Hudson, T L Ratliff
Cancer Treatment and Research|January 1, 1989
Mechanisms of action of intravesical bacillus Calmette-Guerin for bladder cancerD J Mikkelsen, T L Ratliff
In Vivo (Athens, Greece)|November 1, 1991
BCG therapy for superficial bladder cancer: fundamental aspectsM L Hudson, T L Ratliff
Hinyokika Kiyo. Acta Urologica Japonica|January 22, 1998
[Poxvirus vectors for gene transfer]M Kawakita, O Yoshida, T L Ratliff
Acta Urologica Belgica|May 1, 1996
Gene therapyA S Abi-Aad, T L Ratliff
The Journal of Urology|June 1, 1991
Internalization of bacille Calmette-Guerin by bladder tumor cellsM J Becich, S Carroll, T L Ratliff
The Journal of Urology|July 1, 1994
Development of a mouse model for nonbacterial prostatitisD W Keetch, P Humphrey, T L Ratliff
Pageof 13